SCHEMBL3846747

SCHEMBL3846747

O=C(O)c1ccc(-c2ncnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cc23)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 1/20 0.39
CAMKK1 Q8N5S9 1/20 0.37
CAMKK2 Q96RR4 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
PIK3CD O00329 3/20 0.36
PIK3CA P42336 3/20 0.36
PIK3CB P42338 2/20 0.36
MTOR P42345 2/20 0.36
PIK3CG P48736 2/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.35
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGDS O60760 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854353 0.85 KMT2A (0.38) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL3846550 0.84 PIK3CA (0.35) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3845224 0.82 PIK3CD (0.39) ALDH1A1PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL3847105 0.80 CAMKK2 (0.47) CAMKK1CAMKK2PIK3CDPIK3CAPIK3CB
SCHEMBL3848535 0.80 CAMKK1 (0.45) CAMKK1CAMKK2PIK3CDPIK3CAPIK3CB
SCHEMBL10022657 0.80 RAB9A (0.50) RPS6KB2KDM4EALDH1A1GAAPOLB
SCHEMBL3848172 0.74 ACVR1 (0.46) RPS6KB2CAMKK1CAMKK2KDM4EALDH1A1
SCHEMBL3847931 0.74 AURKB (0.43) CAMKK1CAMKK2KDM4EALDH1A1RAB9A
SCHEMBL3847825 0.73 SMN1; SMN2 (0.46) ALDH1A1PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL3848964 0.73 CAMKK1 (0.39) CAMKK1CAMKK2KDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed